Clinical features of thrombophilia in families with gene defects in protein C or protein S combined with factor V Leiden

Blood Coagulation and Fibrinolysis

Volumn 9, Issue 1, 1998, Pages 85-89

  Mustafa, S ^b,c   Mannhalter, C ^b   Rintelen, C ^a   Kyrle, P A ^a   Knobl P ^a   Lechner, K ^a   Pabinger, I ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Factor V genetics; Protein C genetics; Protein S genetics; Thrombophilia risk factors; Thrombosis genetics

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C; PROTEIN S;

ARTICLE; CLINICAL ARTICLE; HUMAN; ONSET AGE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; RECURRENT DISEASE; RISK FACTOR; THROMBOCYTE COUNT; THROMBOPHILIA; THROMBOSIS;

EID: 0031893697     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199801000-00011     Document Type: Article

References (28)

1. Griffin JH, Evatt B, Zimmermann TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-1373.
2. Bovill EG, Bauer KA, Dickermann JD, Callas P, West B. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 1989; 73: 712-717.
3. Koster T, Rosendaal FR, Briët E, van der Meer FJM, Colly LP, Trienekens PH, et al. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood 1995; 85: 2756-2761.
4. Tripodi A, Franchi F, Krachmalnicoff A, Mannucci PM. Asymptomatic homozygous protein C deficiency. Acta Haematol 1990; 83: 152-155.
5. Miletich J, Sherman L, Broze G. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987; 317: 991-996.
6. Tait RC, Walker ID, Reitsma PH, Islam SIAM, McCall F, Poort SR, et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost 1995; 73: 87-93.
7. Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984; 74: 2082-2088.
8. Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood 1984; 64: 1297-1300.
9. Engesser L, Broekmanns AW, Briet E, Brommer EJP, Bertina RM. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 1987; 107: 677-682.
10. Pabinger I, Kyrle PA, Heistinger M, Eichinger S, Wittmann E, Lechner K. The risk of thromboembolism in asymtomatic patients with protein C and protein S deficiency: a prospective cohort study. Thromb Haemost 1994; 71: 441-445.
11. Miletich JP, Prescott SM, White R, Majerus PW, Boville EG. Inherited predisposition to thrombosis. Cell 1993; 72: 477-480.
12. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
13. Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 1994; 84: 1031-1035.
14. Gandrille S, Greengard JS, Alhence-Gelas M, Juhan-Vague I, Abgrall JF, Jude B, Griffin JH, and the French Network on the behalf of INSERM. Incidence of activated protein C resistance caused by the ARG 506 GLN Mutation in factor V in 113 unrelated symptomatic protein C deficient patients. Blood 1995; 86: 219-224.
15. Zöller B, Berntsdotter A, Garcia de Frutos P, Dahlbäck B. Resistance to activated protein C as an additional risk factor in hereditary deficiency of protein S. Blood 1995; 85: 3518-3523.
16. Koeleman BPC, van Rumpt D, Hamulyák K, Reitsma PH, Bertina RM. Factor V Leiden: an additional risk for thrombosis in protein S deficient families? Thromb Haemost 1995; 74: 580-583.
17. Poort SR, Pabinger-Fasching I, Mannhalter C, Reitsma PH, Bertina RM. Twelve novel and two recurrent mutations in 14 Austrian families with hereditary protein C deficiency. Blood Coag Fibrinol 1993; 4: 273-280.
18. Wittmann E, Walter J, Pabinger-Fasching I, Watzke HH. Symptomatic hereditary type II protein C deficiency caused by a missense mutation in exon IX of the protein C gene (Gly 381 to Ser). Ann Hematol 1994; 68: 255-259.
19. Hernández A, Uhrberg M, Enczmann J, Witt I, Reitsma P, Scharrer I, et al. Rapid screening of point mutations in the protein C gene by temperature gradient gel electrophoresis in a group of 44 patients and five families with protein C deficiency. Detection of a novel mutation in the exon IX of the protein C gene (abstract). Experiment Hemat 1995; 23: 772.
20. Mustafa S, Pabinger I, Mannhalter C. Protein S deficiency type I: identification of point mutations in nine of ten families. Blood 1995; 86: 3444-3451.
21. Rintelen C, Pabinger I, Knöbel P, Lechner K, Mannhalter Ch. Probability of recurrence of thrombosis in patients with and without factor V Leiden. Thromb Haemost 1996; 75: 229-232.
22. Kaplan EL, Meier P. Nonparametric estimations from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
23. Mantel M. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
24. Pabinger I, Allart CF, Hermans J, Briët E, Bertina RM, and the Protein C Transmitter Study Group. Hereditary protein C-deficiency: laboratory values in transmitters and guidelines for the diagnostic procedure. Report on a study of the SSC subcommittee on protein C and protein S. Thromb Haemost 1992; 68: 470-474.
25. Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-1506.
26. Griffin JH, Evatt B, Wideman C, Fernandez J. Anticoagulant protein C pathway defective in a majority of thrombophilic patients. Blood 1993; 82: 1989-1993.
27. Martinelli I, Magatelli R, Cattaneo M, Mannucci PM. Prevalence of mutant factor V in Italian patients with hereditary deficiencies of antithrombin, protein C and protein S. Thromb Haemost 1996; 75: 694-695.
28. Pabinger I, Schneider B, for the Gesellschaft für Thrombose- und Haemostaseforschung (GTH) Study Group on Natural Inhibitors. The thrombotic risk in hereditary antithrombin III-, protein C- and protein S-deficiency: a coopers. The thrombotic risk in hereditary antithrombin III-, protein C- and protein S-deficiency: a cooperative retrospective study. Arterioscler Thromb Vasc Biol 1996; 16: 742-748.